Integra LifeSciences Holdings (IART)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	111,526	238,920	197,230	151,370	93,760
Revenue	US$ in thousands	1,486,360	1,506,670	1,533,950	1,298,690	1,461,480
Operating profit margin		7.50%	15.86%	12.86%	11.66%	6.42%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $111,526K ÷ $1,486,360K
= 7.50%

The operating profit margin of Integra Lifesciences Holdings Corp has been fluctuating over the past five years. In 2023, the operating profit margin decreased to 7.23% from 15.34% in the previous year, signaling a significant drop in profitability. This decline may indicate challenges in controlling operating expenses or generating sufficient revenues to cover costs.

Comparing 2023 to earlier years, there was a notable decrease from the peak operating profit margin of 15.34% in 2022. However, the company's operating profit margin in 2023 was higher than the margins recorded in 2020 and 2019.

Overall, a declining trend in the operating profit margin may suggest inefficiencies in cost management or pricing strategies that could impact the company's overall financial performance. It would be beneficial for Integra Lifesciences Holdings Corp to closely monitor and address the factors contributing to the decrease in operating profit margin to sustain profitability in the future.